COMPLETE: International Acute Ischemic Stroke Registry With the Penumbra System Aspiration Including the 3D Revascularization Device

NCT ID: NCT03464565

Last Updated: 2020-12-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

650 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-07-02

Study Completion Date

2020-01-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this registry is to collect performance and safety data on the Penumbra System including the 3D Revascularization Device in a real world patient population with acute ischemic stroke (AIS) secondary to intracranial large vessel occlusion (LVO).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Registry Objective: The primary objective of this registry is to collect real-world performance and safety data on Penumbra System including the 3D Revascularization Device in a patient population with acute ischemic stroke (AIS) secondary to intracranial large vessel occlusion (LVO).

Registry Design: This will be a prospective, single-arm, multi-center observational registry and will include patients that present with either anterior or posterior LVO who are eligible for mechanical thrombectomy using the Penumbra System.

Registry Duration: Subjects will be in the registry for approximately 90 days from enrollment to last follow-up.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke, Ischemic

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Large Vessel Occlusion Acute Ischemic Stroke Mechanical Thrombectomy Penumbra System 3D Revascularization

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with acute ischemic stroke secondary to LVO

Penumbra System

Intervention Type DEVICE

Penumbra System

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Penumbra System

Penumbra System

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient age ≥ 18
* Pre-stroke mRS 0-1
* Patient experiencing acute ischemic stroke secondary to intracranial large vessel occlusion who are eligible for mechanical thrombectomy using the Penumbra System
* Planned frontline treatment with Penumbra System
* Signed informed consent per Institution Review Board/Ethics Committee

Exclusion Criteria

* Any comorbid disease or condition expected to compromise survival or ability to complete follow-up assessments through 90 days.
* Currently participating in an investigational (drug, device, etc) clinical trial that will confound study endpoints. Patients in observational, natural history, and/or epidemiological studies not involving intervention are eligible.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Penumbra Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Osama O Zaidat, MD

Role: PRINCIPAL_INVESTIGATOR

Mercy St. Vincent Medical Center

Johanna Fifi, MD

Role: PRINCIPAL_INVESTIGATOR

Mount Sinai Health System

Ameer E. Hassan, MD

Role: PRINCIPAL_INVESTIGATOR

McAllen Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Banner Desert Medical Center

Mesa, Arizona, United States

Site Status

Eden Medical Center

Castro Valley, California, United States

Site Status

St. Jude Medical Center

Fullerton, California, United States

Site Status

Cedar Sinai Medical Center

Los Angeles, California, United States

Site Status

Mercy San Juan Medical Center

Sacramento, California, United States

Site Status

Los Robles Hospital

Thousand Oaks, California, United States

Site Status

RIA

Englewood, Colorado, United States

Site Status

Yale New Haven Hospital

New Haven, Connecticut, United States

Site Status

Jackson Memorial Hospital

Miami, Florida, United States

Site Status

Naples Community Hospital

Naples, Florida, United States

Site Status

AdventHealth Orlando

Orlando, Florida, United States

Site Status

University of Kansas Medical Center

Kansas City, Kansas, United States

Site Status

Oschner Medical Center

New Orleans, Louisiana, United States

Site Status

Brigham & Women's Hospital

Boston, Massachusetts, United States

Site Status

SSM St. Clare Healthcare

St Louis, Missouri, United States

Site Status

The Valley Hospital

Ridgewood, New Jersey, United States

Site Status

Northwell Health

Manhasset, New York, United States

Site Status

Mount Sinai New York

New York, New York, United States

Site Status

NYU Langone Hospital-Brooklyn

New York, New York, United States

Site Status

Mercy St. Vincent Medical Center

Toledo, Ohio, United States

Site Status

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, United States

Site Status

Palmetto Health Richland Hospital

Columbia, South Carolina, United States

Site Status

Erlanger Health System

Chattanooga, Tennessee, United States

Site Status

Fort Sanders Regional Medical Center

Knoxville, Tennessee, United States

Site Status

Methodist University Hospital

Memphis, Tennessee, United States

Site Status

Valley Baptist Medical Center

Harlingen, Texas, United States

Site Status

Houston Methodist Hospital

Houston, Texas, United States

Site Status

McAllen Medical Center

McAllen, Texas, United States

Site Status

Swedish Medical Center-Cherry Hill

Seattle, Washington, United States

Site Status

CHU de Bordeaux - Hôpital Pellegrin

Bordeaux, , France

Site Status

Foundation Ophthalmic Adolphe De Rothschild

Paris, , France

Site Status

Charité - Universitätsmedizin Berlin

Berlin, , Germany

Site Status

Klinikum Chemnitz gGmbH

Chemnitz, , Germany

Site Status

Universitätsklinikum Erlangen

Erlangen, , Germany

Site Status

Universitätsklinikum Schleswig-Holstein Campus Lübeck

Lübeck, , Germany

Site Status

Universitätsklinikum Magdeburg A. ö. R.

Magdeburg, , Germany

Site Status

Samodzielny Publiczny Szpital Kliniczny

Lublin, , Poland

Site Status

Davidovsky Moscow City Hospital №23

Moscow, , Russia

Site Status

City Clinical Hospital No. 1

Moscow, , Russia

Site Status

Multidisciplinary City Hospital №2

Saint Petersburg, , Russia

Site Status

Hospital Universitari Vall d'Hebron

Barcelona, , Spain

Site Status

Hospital Clínico Universitario Virgen de la Arrixaca

Murcia, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States France Germany Poland Russia Spain

References

Explore related publications, articles, or registry entries linked to this study.

Hassan AE, Fifi JT, Zaidat OO. Aspiration thrombectomy with the Penumbra System for patients with stroke and late onset to treatment: a subset analysis of the COMPLETE registry. Front Neurol. 2023 Sep 14;14:1239640. doi: 10.3389/fneur.2023.1239640. eCollection 2023.

Reference Type DERIVED
PMID: 37794880 (View on PubMed)

Hassan AE, Zaidat OO, Nanda A, Atchie B, Woodward K, Doerfler A, Tomasello A, Fifi JT. Impact of interhospital transfer vs. direct admission on acute ischemic stroke patients: A subset analysis of the COMPLETE registry. Front Neurol. 2022 Aug 9;13:896165. doi: 10.3389/fneur.2022.896165. eCollection 2022.

Reference Type DERIVED
PMID: 36016541 (View on PubMed)

Zaidat OO, Fifi JT, Nanda A, Atchie B, Woodward K, Doerfler A, Tomasello A, Tekle W, Singh IP, Matouk C, Thalwitzer J, Jargiello T, Skrypnik D, Beuing O, Berge J, Katz JM, Biondi A, Bonovich D, Sheth SA, Yoo AJ, Hassan AE; COMPLETE Registry Investigators. Endovascular Treatment of Acute Ischemic Stroke With the Penumbra System in Routine Practice: COMPLETE Registry Results. Stroke. 2022 Mar;53(3):769-778. doi: 10.1161/STROKEAHA.121.034268. Epub 2021 Sep 22.

Reference Type DERIVED
PMID: 34547927 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

12965

Identifier Type: -

Identifier Source: org_study_id